(Q28570444)

31 January 2017

title

Mutation of active site residues of insulin-degrading enzyme alters allosteric interactions (English)

1 reference

31 January 2017

1 reference

Eun Suk Song

1

1 reference

31 January 2017

Abigail Daily

2

1 reference

31 January 2017

Michael G. Fried

3

1 reference

31 January 2017

Maria Aparecida Juliano

4

1 reference

31 January 2017

Luiz Juliano

5

1 reference

31 January 2017

Louis B. Hersh

6

1 reference

31 January 2017

language of work or name

English

0 references

publication date

6 May 2005

1 reference

Journal of Biological Chemistry

31 January 2017

published in

1 reference

31 January 2017

volume

280

1 reference

31 January 2017

issue

18

1 reference

31 January 2017

page(s)

17701–17706

1 reference

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Kinetics of amyloid beta-protein degradation determined by novel fluorescence- and fluorescence polarization-based assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Clearing amyloid through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Peptidases, proteases and amyloid beta-peptide catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Neprilysin regulates amyloid Beta peptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Susceptibility locus for Alzheimer's disease on chromosome 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Insulin degradation: progress and potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Overexpression of insulin degrading enzyme: cellular localization and effects on insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Identification of gamma-endorphin-generating enzyme as insulin-degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Insulin-degrading enzyme: embarking on amyloid destruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Substrate activation of insulin-degrading enzyme (insulysin). A potential target for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Prediction of protein secondary structure at better than 70% accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Mutation of active site residues of the puromycin-sensitive aminopeptidase: conversion of the enzyme into a catalytically inactive binding protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

ATP effects on insulin-degrading enzyme are mediated primarily through its triphosphate moiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Leukotriene A4 hydrolase: abrogation of the peptidase activity by mutation of glutamic acid-296

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

Identification of glutamate residues essential for catalytic activity and zinc coordination in aminopeptidase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501896200

21 January 2018

Identifiers

DOI

10.1074/JBC.M501896200

1 reference

31 January 2017

1 reference